Reduced intensity <scp>VEPEMB</scp> regimen compared with standard <scp>ABVD</scp> in elderly Hodgkin lymphoma patients: results from a randomized trial on behalf of the Fondazione Italiana Linfomi (<scp>FIL</scp>)
British journal of haematology